Saudi health insurance now covers more than 14 million people and drives most of the market’s growth. The line to watch is not enrolment — it is medical cost inflation.
Health is the engine of the Saudi insurance market, and the engine is running hot. The Insurance Authority's 2025 results counted more than 14 million health insurance beneficiaries, and health alone contributed roughly 68% of the year's premium growth — in a market that grew 10.7% overall to SAR 84.3 billion. Enrolment is a solved problem; the employer mandate solved it. The unsolved problem, and the one that will define the next several years, is the cost curve underneath.
The numbers first
- More than 14 million people carry health insurance in Saudi Arabia, per the Authority's 2025 results.
- Health insurance contributed approximately 68% of the market's total premium growth in 2025; health and motor together contributed nearly 89%.
- Total market claims paid rose 10% to SAR 53 billion in 2025 — with health, as the largest line, the biggest component.
- Regionally, WTW's Global Medical Trends survey put Middle East healthcare cost increases at 8.5% in 2024 and 10.3% in 2025, with a forecast of 11.3% for 2026.
- Milliman's read of listed insurers' 2025 results shows the sector loss ratio rising to 89.3% from 86.7%, and net profit ratio contracting to 3.1% from 5.7%.
One caveat before the analysis: the WTW figures are a regional Middle East trend, not a Saudi-specific series. We use them as the best available directional indicator, and the direction is unambiguous — medical costs are compounding at double digits.
Why the cost curve is the story
An insurance line can grow premiums two ways: cover more people, or charge more per person. Saudi health insurance spent a decade doing the first, as the employer mandate administered by the Council of Health Insurance brought private-sector workforces and their dependants into cover. With more than 14 million beneficiaries, the enrolment frontier is maturing. From here, premium growth increasingly means price — and price is being pushed hard from below by utilisation and unit-cost inflation across the region's healthcare systems.
That is what a 10% rise in claims paid against 10.7% premium growth signals: the market is roughly treading water against its own cost base. The Authority itself has flagged medical cost inflation as a watch item. When the input cost of a product compounds at around 10% a year, one of three things happens — premiums follow, benefits thin, or margins vanish. In 2025 the third showed up first: profitability metrics across the listed sector deteriorated sharply even as revenue grew.
Mandate economics
The employer mandate shapes this market in ways that are easy to miss from the aggregate numbers. Group medical is a business-to-business purchase, renegotiated annually, where the buyer is an HR or finance function balancing cost against workforce expectations. Under cost inflation, the annual renewal becomes a benefits-design negotiation: networks narrow, co-pays move, plan tiers multiply. The premium line in the market statistics is the residue of thousands of those negotiations.
It also concentrates the market. Serving large group schemes profitably requires provider-network scale and claims infrastructure, which is why health margins hold up better at the largest insurers than the rest of the field. Growth driven by a line with these economics tends to widen the gap between the market's leaders and its long tail.
What the cost curve means for distribution
For platforms and employers, three practical consequences follow. First, expect annual repricing as the norm, not the exception — build renewals, comparison and switching into any health journey, because a static quote ages badly. Second, the underserved edge of the mandate — small employers assembling their first group policy — is where digital distribution has the most to add, since brokers' economics favour large schemes. Third, benefits literacy becomes a product feature: when plans differentiate on networks and co-pays rather than price alone, the interface that explains the difference clearly wins the renewal.
Sources and limits
Beneficiary counts, growth contributions and claims figures come from the Insurance Authority's published 2025 results via the Saudi Press Agency. Sector profitability figures come from Milliman's analysis of listed insurers' IFRS 17 disclosures. Medical trend figures are WTW's Middle East regional survey numbers, not a Saudi-only measure, and we have labelled them as such. Statements about mandate dynamics, renewal behaviour and margin concentration are our interpretation of how the line works, informed by the cited data rather than drawn from a single published statistic.